Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase for Late-Window Acute Ischemic Stroke Without EVT Access
NCT07168278Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Nov 2025
- Primary completion
- Mar 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by The First Affiliated Hospital of University of Science and Technology of China. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07168278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07168278.